Asparagine-linked glycosylation of bone morphogenetic protein-2 is required for secretion and osteoblast differentiation

Glycobiology

Volumn 24, Issue 3, 2014, Pages 292-304

  Hang, Qinglei ^a,b   Zhou, Ying ^a   Hou, Sicong ^c   Zhang, Dongmei ^a   Yang, Xiaojing ^a   Chen, Jianping ^a   Ben, Zhiyun ^a   Cheng, Chun ^a   Shen, Aiguo ^a  

^a NANTONG UNIVERSITY   (China)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

Author keywords

bone morphogenetic protein 2; CHO cells; MC3T3 E1 cells; N glycosylation; osteoblast differentiation

Indexed keywords

BONE MORPHOGENETIC PROTEIN-2; CHO CELLS; MC3T3-E1 CELLS; N-GLYCOSYLATION; OSTEOBLAST DIFFERENTIATION;

ANIMALS; ASPARAGINE; BONE MORPHOGENETIC PROTEIN 2; CHO CELLS; CRICETINAE; CRICETULUS; GLYCOSYLATION; HEK293 CELLS; HUMANS; MICE; MUTATION; OSTEOBLASTS; OSTEOGENESIS; PROTEIN FOLDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT;

EID: 84894248251     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwt110     Document Type: Article

References (59)

1. Bence M, Sahin-Toth M. 2011. Asparagine-linked glycosylation of human chymotrypsin C is required for folding and secretion but not for enzyme activity. FEBS J. 278:4338-4350.
2. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. 2000. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol. 2:326-332.
3. Cabral CM, Liu Y, Sifers RN. 2001. Dissecting glycoprotein quality control in the secretory pathway. Trends Biochem Sci. 26:619-624.
4. Canalis E, Economides AN, Gazzerro E. 2003. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev. 24:218-235.
5. Chen D, Harris MA, Rossini G, Dunstan CR, Dallas SL, Feng JQ, Mundy GR, Harris SE. 1997. Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif Tissue Int. 60:283-290.
6. Chen C, Uludag H, Wang Z, Jiang H. 2012. Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells in vitro. J Cell Biochem. 113:3672-3680.
7. Chen D, Zhao M, Mundy GR. 2004. Bone morphogenetic proteins. Growth Factors. 22:233-241.
8. Davis HE, Case EM, Miller SL, Genetos DC, Leach JK. 2011. Osteogenic response to BMP-2 of hMSCs grown on apatite-coated scaffolds. Biotechnol Bioeng. 108:2727-2735.
9. Doms RW, Helenius A, White J. 1985. Membrane fusion activity of the influenza virus hemagglutinin. The low pH-induced conformational change. J Biol Chem. 260:2973-2981.
10. Ducy P, Karsenty G. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol. 15:1858-1869.
11. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G. 1999. ACbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13:1025-1036.
12. Dwek RA, Butters TD, Platt FM, Zitzmann N. 2002. Targeting glycosylation as a therapeutic approach. Nat Rev Drug Discov. 1:65-75.
13. Freeze HH. 2006. Genetic defects in the human glycome. Nat Rev Genet. 7:537-551.
14. Garrigue-Antar L, Hartigan N, Kadler KE. 2002. Post-translational modification of bone morphogenetic protein-1 is required for secretion and stability of the protein. J Biol Chem. 277:43327-43334.
15. Gavel Y, von Heijne G. 1990. Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: Implications for protein engineering. Protein Eng. 3:433-442.
16. Hang Q, Fei M, Hou S, Ni Q, Lu C, Zhang G, Gong P, Guan C, Huang X, He S. 2012. Expression of Spy1 protein in human non-Hodgkin's lymphomas is correlated with phosphorylation of p27 Kip1 on Thr187 and cell proliferation. Med Oncol. 29:3504-3514.
17. Hayashi H, Yamashita Y. 2012. Role of N-glycosylation in cell surface expression and protection against proteolysis of the intestinal anion exchanger SLC26A3. Am J Physiol Cell Physiol. 302:C781-C795.
18. Hebert DN, Zhang JX, Chen W, Foellmer B, Helenius A. 1997. The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. J Cell Biol. 139:613-623.
19. Helenius A, Aebi M. 2001. Intracellular functions of N-linked glycans. Science. 291:2364-2369.
20. Helenius A, Aebi M. 2004. Roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem. 73:1019-1049.
21. Israel DI, Nove J, Kerns KM, Moutsatsos IK, Kaufman RJ. 1992. Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells. Growth Factors. 7:139-150.
22. Jacob GS. 1995. Glycosylation inhibitors in biology and medicine. Curr Opin Struct Biol. 5:605-611.
23. Jang WG, Kim EJ, Kim DK, Ryoo HM, Lee KB, Kim SH, Choi HS, Koh JT. 2012. BMP2 protein regulates osteocalcin expression via Runx2-mediated Atf6 gene transcription. J Biol Chem. 287:905-915.
24. Javed A, Barnes GL, Jasanya BO, Stein JL, Gerstenfeld L, Lian JB, Stein GS. 2001. runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: Evidence for promoter context-dependent activity of Cbfa proteins. Mol Cell Biol. 21:2891-2905.
25. Kadowaki T, Tsukuba T, Bertenshaw GP, Bond JS. 2000. N-Linked oligosaccharides on the meprin A metalloprotease are important for secretion and enzymatic activity, but not for apical targeting. J Biol Chem. 275:25577-25584.
26. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T. 1990. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun. 172:295-299.
27. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. 1994. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol. 127:1755-1766.
28. Kobata A. 1992. Structures and functions of the sugar chains of glycoproteins. Eur J Biochem. 209:483-501.
29. Komori T. 2006. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem. 99:1233-1239.
30. Mahoney DJ, Mikecz K, Ali T, Mabilleau G, Benayahu D, Plaas A, Milner CM, Day AJ, Sabokbar A. 2008. TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation. J Biol Chem. 283:25952-25962.
31. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding HP, Ron D. 2004. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 18:3066-3077.
32. Miletich JP, Broze GJ, Jr. 1990. Beta protein C is not glycosylated at asparagine 329. The rate of translation may influence the frequency of usage at asparagine-X-cysteine sites. J Biol Chem. 265:11397-11404.
33. Molinari M, Helenius A. 2000. Chaperone selection during glycoprotein translocation into the endoplasmic reticulum. Science. 288:331-333.
34. Morais VA, Costa MT, Costa J. 2003. N-glycosylation of recombinant human fucosyltransferase III is required for its in vivo folding in mammalian and insect cells. Biochim Biophys Acta. 1619:133-138.
35. Ohtsubo K, Marth JD. 2006. Glycosylation in cellular mechanisms of health and disease. Cell. 126:855-867.
36. Park C, Zhang J. 2011. Genome-wide evolutionary conservation of N-glycosylation sites. Mol Biol Evol. 28:2351-2357.
37. Parodi AJ. 2000. Protein glucosylation and its role in protein folding. Annu Rev Biochem. 69:69-93.
38. Ray K, Clapp P, Goldsmith PK, Spiegel AM. 1998. Identification of the sites of N-linked glycosylation on the human calcium receptor and assessment of their role in cell surface expression and signal transduction. J Biol Chem. 273:34558-34567.
39. Rek A, Krenn E, Kungl AJ. 2009. Therapeutically targeting protein-glycan interactions. Br J Pharmacol. 157:686-694.
40. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. 2001. Glycosylation and the immune system. Science. 291:2370-2376.
41. Ruusala A, Persson R, Schmaljohn CS, Pettersson RF. 1992. Coexpression of the membrane glycoproteins G1 and G2 of Hantaan virus is required for targeting to the Golgi complex. Virology. 186:53-64.
42. Saito A, Ochiai K, Kondo S, Tsumagari K, Murakami T, Cavener DR, Imaizumi K. 2011. Endoplasmic reticulum stress response mediated by the PERK-eIF2(alpha)-ATF4 pathway is involved in osteoblast differentiation induced by BMP2. J Biol Chem. 286:4809-4818.
43. Sakano S, Murata Y, Miura T, Iwata H, Sato K, Matsui N, Seo H. 1993. Collagen and alkaline phosphatase gene expression during bone morphogenetic protein (BMP)-induced cartilage and bone differentiation. Clin Orthop Relat Res. 292:337-344.
44. Saremba S, Nickel J, Seher A, Kotzsch A, Sebald W, Mueller TD. 2008. Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand. FEBS J. 275:172-183.
45. Schmieder S, Lindenthal S, Ehrenfeld J. 2001. Tissue-specific N-glycosylation of the ClC-3 chloride channel. Biochem Biophys Res Commun. 286:635-640.
46. Simizu S, Ishida K, Wierzba MK, Osada H. 2004. Secretion of heparanase protein is regulated by glycosylation in human tumor cell lines. J Biol Chem. 279:2697-2703.
47. Sun PD, Davies DR. 1995. The cystine-knot growth-factor superfamily. Annu Rev Biophys Biomol Struct. 24:269-291.
48. Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K. 1991. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun. 174:96-101.
49. Trombetta ES, Parodi AJ. 2003. Quality control and protein folding in the secretory pathway. Annu Rev Cell Dev Biol. 19:649-676.
50. Tsukuba T, Bond JS. 1998. Role of the COOH-terminal domains of meprin A in folding, secretion, and activity of the metalloendopeptidase. J Biol Chem. 273:35260-35267.
51. Vagin O, Tokhtaeva E, Yakubov I, Shevchenko E, Sachs G. 2008. Inverse correlation between the extent of N-glycan branching and intercellular adhesion in epithelia. Contribution of the Na,K-ATPase beta1 subunit. J Biol Chem. 283:2192-2202.
52. Wang XZ, Ron D. 1996. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. Science. 272:1347-1349.
53. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, et al. 1990. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA. 87:2220-2224.
54. Welch RD, Jones AL, Bucholz RW, Reinert CM, Tjia JS, Pierce WA, Wozney JM, Li XJ. 1998. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model. J Bone Miner Res. 13:1483-1490.
55. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. 1988. Novel regulators of bone formation: Molecular clones and activities. Science. 242:1528-1534.
56. Wujek P, Kida E, Walus M, Wisniewski KE, Golabek AA. 2004. N-glycosylation is crucial for folding, trafficking, and stability of human tripeptidyl-peptidase I. J Biol Chem. 279:12827-12839.
57. Yamaguchi A, Komori T, Suda T. 2000. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev. 21:393-411.
58. Zhao M, Harris SE, Horn D, Geng Z, Nishimura R, Mundy GR, Chen D. 2002. Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J Cell Biol. 157:1049-1060.
59. Zhou YB, Liu F, Zhu ZD, Zhu H, Zhang X, Wang ZQ, Liu JH, Han ZG. 2004. N-glycosylation is required for efficient secretion of a novel human secreted glycoprotein, hPAP21. FEBS Lett. 576: 401-407.